5-day/5-drug myeloablative outpatient regimen for resistant neuroblastoma
Year: 2012
Type: article
Study design: Clinical Trial
Source: Bone Marrow Transplantation
DOI: 10.1038/bmt.2012.202
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
Award: G4961134886
OpenAlex ID: W2030793090
